Jane Wasman

2015

In 2015, Jane Wasman earned a total compensation of $2M as President, International, General Counsel and Corporate Secretary at Acorda Therapeutics, a 16% decrease compared to previous year.

Compensation breakdown

Bonus$17,000
Non-Equity Incentive Plan$316,007
Option Awards$801,034
Salary$552,408
Stock Awards$259,794
Other$7,950
Total$1,954,193

Wasman received $801K in option awards, accounting for 41% of the total pay in 2015.

Wasman also received $17K in bonus, $316K in non-equity incentive plan, $552.4K in salary, $259.8K in stock awards and $8K in other compensation.

Rankings

In 2015, Jane Wasman's compensation ranked 4,807th out of 13,638 executives tracked by ExecPay. In other words, Wasman earned more than 64.8% of executives.

ClassificationRankingPercentile
All
4,807
out of 13,638
65th
Division
Manufacturing
1,766
out of 5,190
66th
Major group
Chemicals And Allied Products
628
out of 1,854
66th
Industry group
Drugs
498
out of 1,528
67th
Industry
Biological Products, Except Diagnostic Substances
81
out of 254
68th
Source: SEC filing on April 21, 2017.

Wasman's colleagues

We found six more compensation records of executives who worked with Jane Wasman at Acorda Therapeutics in 2015.

2015

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2015

Enrique Carrazana

Acorda Therapeutics

Chief Medical Officer

2015

Michael Rogers

Acorda Therapeutics

Chief Financial Officer

2015

Lauren Sabella

Acorda Therapeutics

Chief Commercial Officer

2015

David Lawrence

Acorda Therapeutics

Chief, Business Operations and Principal Accounting Officer

2015

Andrew Hindman

Acorda Therapeutics

Chief Business Development Officer

News

You may also like